Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | PKM | P14618 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | ATM | Q13315 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | LCK | P06239 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21775985 | 0.87 | ALDH1A1 (0.33) | ALDH1A1MAPTHPGDKMT2A | |
| SCHEMBL21156737 | 0.86 | ALDH1A1 (0.31) | ALDH1A1MAPTHPGDKMT2A | |
| SCHEMBL21776014 | 0.85 | KMT2A (0.31) | MEN1ALDH1A1MAPTPKMHPGD | |
| SCHEMBL19917226 | 0.84 | — | — | |
| SCHEMBL24060713 | 0.84 | ALDH1A1 (0.30) | ALDH1A1MAPTHPGDKMT2A | |
| SCHEMBL21156735 | 0.82 | — | — | |
| SCHEMBL21776032 | 0.81 | ALDH1A1 (0.32) | ALDH1A1MAPTHPGDKMT2A | |
| SCHEMBL22382789 | 0.79 | LCK (0.36) | MEN1ALDH1A1MAPTPKMHPGD | |
| SCHEMBL21775988 | 0.78 | KMT2A (0.31) | MEN1ALDH1A1MAPTPKMHPGD | |
| SCHEMBL21776017 | 0.77 | KMT2A (0.34) | MEN1ALDH1A1MAPTPKMHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200066998-A1 | ORGANIC SEMICONDUCTING COMPONDS | MERCK PATENT GMBH (DE) | 2020-02-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200066998-A1 | ORGANIC SEMICONDUCTING COMPONDS | EED, OCIAD2, OCIAD1 | KDM4E 576/4885MEN1 1917/4885ALDH1A1 2698/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.